Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regenxbio (RGNX) Change in Acquisitions & Divestments (2016 - 2025)

Regenxbio (RGNX) has 10 years of Change in Acquisitions & Divestments data on record, last reported at -$136.0 million in Q3 2025.

  • For Q3 2025, Change in Acquisitions & Divestments fell 256.67% year-over-year to -$136.0 million; the TTM value through Dec 2025 reached $62000.0, down 98.93%, while the annual FY2025 figure was $62000.0, 98.93% down from the prior year.
  • Change in Acquisitions & Divestments reached -$136.0 million in Q3 2025 per RGNX's latest filing, down from $71.1 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $107.6 million in Q2 2023 and bottomed at -$232.7 million in Q4 2024.
  • Average Change in Acquisitions & Divestments over 5 years is $12.0 million, with a median of $50.2 million recorded in 2021.
  • Peak YoY movement for Change in Acquisitions & Divestments: plummeted 632.99% in 2021, then soared 190.55% in 2023.
  • A 5-year view of Change in Acquisitions & Divestments shows it stood at -$130.8 million in 2021, then soared by 133.74% to $44.1 million in 2022, then plummeted by 493.17% to -$173.5 million in 2023, then plummeted by 34.08% to -$232.7 million in 2024, then skyrocketed by 41.56% to -$136.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Acquisitions & Divestments were -$136.0 million in Q3 2025, $71.1 million in Q2 2025, and $64.9 million in Q1 2025.